Skip to main content

Morning Bell 13 April

Jessica Amir
April 13, 2021

Vaccine talks will dominate local headlines today for two reasons – the Federal government has taken the J&J vaccine off the table and ScoMo has said that Aussies will likely not receive a vaccine by the end of year.

This means travel and tourism stocks will be back in focus, in particular Qantas (ASX:QAN), as the company planned to initially resume international flights in October as Australians were initially set to be vaccinated by then.

 What to watch today:  

  • The Aussie market is expected to rise 0.2% if the futures are correct.
  • New home sales and business confidence data out today.
  • Keep an eye on the most traded stocks from yesterday. For our active trader desk, Bell Direct Advantage they were: Delorean (ASX:DEL) which listed on the ASX on Monday, and Digital Wine Ventures (ASX:DW8).

Trading ideas:

  • The a2Milk Company (ASX:A2M) was upgraded from a Hold to a Buy with an increased price target of $9.50 as China distribution is showing strong signs of early life.
  • Macquarie rated Dexus (ASX:DXS) as a Buy with a $10.33 target and an estimated dividend yield of 4.53%.
  • Galan Lithium (ASX:GLN), Mach7 Technologies (ASX:M7T), People Infrastructure (ASX:PPE) are all giving off bullish charting signals according to Trading Central.

Market Update

Julia Lee
March 31, 2017

Market Update

Julia Lee
March 30, 2017

March Overview

Julia Lee
March 28, 2017

Market Update

Julia Lee
March 27, 2017

Market Update

Julia Lee
March 23, 2017

Market Update

Julia Lee
March 22, 2017

Market Update

Julia Lee
March 20, 2017

Market Update

Julia Lee
March 17, 2017

Market Update

Julia Lee
March 16, 2017

Market Update 15 March 2017

Julia Lee
March 15, 2017

How to review your portfolio

Bell Direct
March 14, 2017